Literature DB >> 7534679

Nonsurgical management of primary cholangiocarcinoma. Retrospective analysis of 40 cases.

B Banerjee1, S K Teplick.   

Abstract

Forty patients with cholangiocarcinoma (23 men, 17 women) underwent nonsurgical palliative biliary drainage over a period of 12 years. All were surgically unfit or had unresectable disease. All were jaundiced at presentation with a mean serum bilirubin of 11.5 +/- 1.9 mg/dl. Thirty patients (75%) had hilar obstruction. Twenty-eight were drained percutaneously, three endoscopically and nine by a combined endoscopic and percutaneous procedure. Technical success was 97.5%. Final mean bilirubin was 1.5 +/- 0.4 mg/dl. Minor complications occurred in 10 (25%) patients, and major complications in four (10%). Procedure-related mortality was 2.5% with a 30-day mortality of 7.5%. Mean survival was 8.2 +/- 0.5 months. Stent changes were required in eight patients. In patients with inoperable or unresectable cholangiocarcinoma, percutaneous or endoscopic biliary drainage offers effective palliation.

Entities:  

Mesh:

Year:  1995        PMID: 7534679     DOI: 10.1007/bf02064393

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Carcinoma of the extrahepatic bile ducts; review of the literature and report of six cases.

Authors:  K SAKO; G L SEITZINGER; E GARSIDE
Journal:  Surgery       Date:  1957-03       Impact factor: 3.982

2.  Symptom relief and quality of life after stenting for malignant bile duct obstruction.

Authors:  A B Ballinger; M McHugh; S M Catnach; E M Alstead; M L Clark
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

Review 3.  Upper intestinal and biliary tract endoprosthesis.

Authors:  G N Tytgat; J F Bartelsman; F C Den Hartog Jager; K Huibregtse; E M Mathus-Vliegen
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

4.  Percutaneous transhepatic endoprosthesis in malignant obstruction of the bile duct.

Authors:  T Yamakawa; R D Esguerra; H Kaneko; E Fukuma
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

5.  Bypass procedure for bile duct cancer.

Authors:  K Miyazaki; K Nagafuchi; F Nakayama
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

6.  Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer.

Authors:  R Pichlmayr; B Ringe; W Lauchart; W O Bechstein; G Gubernatis; E Wagner
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

7.  Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma.

Authors:  Y Nakanuma; T Terada; Y Tanaka; G Ohta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

8.  Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey.

Authors:  R Reding; J L Buard; G Lebeau; B Launois
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

9.  Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer.

Authors:  G Falkson; J M MacIntyre; C G Moertel
Journal:  Cancer       Date:  1984-09-15       Impact factor: 6.860

10.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02
View more
  6 in total

1.  Diagnosis, Staging, and Treatment of Cholangiocarcinoma.

Authors:  Jung-Hwan Yoon; Gregory J. Gores
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

2.  Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction.

Authors:  T Nomura; Y Shirai; K Hatakeyama
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

3.  Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.

Authors:  A Tannapfel; L Weinans; F Geissler; A Schütz; A Katalinic; F Köckerling; J Hauss; C Wittekind
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

4.  Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures.

Authors:  S H Zidi; F Prat; O Le Guen; Y Rondeau; G Pelletier
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

5.  Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma.

Authors:  Vajarabhongsa Bhudhisawasdi; Kanha Muisuk; Premjai Areejitranusorn; Churairat Kularbkaew; Tueanjit Khampitak; O-Tur Saeseow; Sopit Wongkham
Journal:  J Cancer Res Clin Oncol       Date:  2003-11-28       Impact factor: 4.553

Review 6.  [Palliative therapy of carcinomas of the biliary system].

Authors:  C Lersch; M Classen
Journal:  Med Klin (Munich)       Date:  1997-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.